131 related articles for article (PubMed ID: 11690682)
1. Radiation therapy for loco-regionally recurrent esophageal cancer after surgery.
Nemoto K; Ariga H; Kakuto Y; Matsushita H; Takeda K; Takahashi C; Takai Y; Yamada S; Hosoi Y
Radiother Oncol; 2001 Nov; 61(2):165-8. PubMed ID: 11690682
[TBL] [Abstract][Full Text] [Related]
2. Salvage radiotherapy for postoperative loco-regional recurrence of esophageal cancer.
Yamashita H; Nakagawa K; Tago M; Nakamura N; Shiraishi K; Ohtomo K
Dis Esophagus; 2005; 18(4):215-20. PubMed ID: 16128776
[TBL] [Abstract][Full Text] [Related]
3. Radiation therapy for recurrent esophageal cancer after surgery: clinical results and prognostic factors.
Shioyama Y; Nakamura K; Ohga S; Nomoto S; Sasaki T; Yamaguchi T; Toba T; Yoshitake T; Terashima H; Honda H
Jpn J Clin Oncol; 2007 Dec; 37(12):918-23. PubMed ID: 18211982
[TBL] [Abstract][Full Text] [Related]
4. Local field radiotherapy without elective nodal irradiation for postoperative loco-regional recurrence of esophageal cancer.
Kimoto T; Yamazaki H; Suzuki G; Aibe N; Masui K; Tatekawa K; Sasaki N; Fujiwara H; Shiozaki A; Konishi H; Nakamura S; Yamada K
Jpn J Clin Oncol; 2017 Sep; 47(9):809-814. PubMed ID: 28903531
[TBL] [Abstract][Full Text] [Related]
5. Local-regional control of recurrent breast carcinoma after mastectomy: does hyperfractionated accelerated radiotherapy improve local control?
Ballo MT; Strom EA; Prost H; Singletary SE; Theriault RL; Buchholz TA; McNeese MD
Int J Radiat Oncol Biol Phys; 1999 Apr; 44(1):105-12. PubMed ID: 10219802
[TBL] [Abstract][Full Text] [Related]
6. Concurrent chemoradiotherapy with protracted infusion of 5-FU and cisplatin for postoperative recurrent or residual esophageal cancer.
Nishimura Y; Koike R; Nakamatsu K; Kanamori S; Suzuki M; Shigeoka H; Shiozaki H
Jpn J Clin Oncol; 2003 Jul; 33(7):341-5. PubMed ID: 12949060
[TBL] [Abstract][Full Text] [Related]
7. Involved-field chemoradiotherapy for postoperative solitary lymph node recurrence of esophageal cancer.
Kawamoto T; Nihei K; Sasai K; Karasawa K
Esophagus; 2018 Oct; 15(4):256-262. PubMed ID: 30225742
[TBL] [Abstract][Full Text] [Related]
8. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
9. [Outcome and prognostic factors of 125 loco-regionally advanced head and neck squamous cell carcinoma treated with multi-modality treatment].
Qian W; Zhu G; Ji Q; Guo Y; Wang Y; Wang Y
Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):217-22. PubMed ID: 24785284
[TBL] [Abstract][Full Text] [Related]
10. Elective nodal irradiation is not necessary in chemoradiotherapy for postoperative loco-regional recurrent esophageal cancer.
Jingu K; Umezawa R; Yamamoto T; Matsushita H; Ishikawa Y; Kozumi M; Kubozono M; Takahashi N; Kadoya N; Takeda K
Jpn J Clin Oncol; 2017 Mar; 47(3):200-205. PubMed ID: 28031356
[TBL] [Abstract][Full Text] [Related]
11. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
12. Patterns of failure associated with involved field radiotherapy in patients with clinical stage I thoracic esophageal cancer.
Kawaguchi Y; Nishiyama K; Miyagi K; Suzuki O; Ito Y; Nakamura S
Jpn J Clin Oncol; 2011 Aug; 41(8):1007-12. PubMed ID: 21665908
[TBL] [Abstract][Full Text] [Related]
13. High dose radiation with chemotherapy followed by salvage esophagectomy among patients with locally advanced esophageal squamous cell carcinoma.
Lertbutsayanukul C; Tharavej C; Klaikeaw N; Prayongrat A; Lowanitchai C; Sriuranpong V
Thorac Cancer; 2017 May; 8(3):219-228. PubMed ID: 28322515
[TBL] [Abstract][Full Text] [Related]
14. Combined radiochemotherapy for postoperative recurrence of oesophageal cancer.
Raoul JL; Le Prisé E; Meunier B; Julienne V; Etienne PL; Gosselin M; Launois B
Gut; 1995 Aug; 37(2):174-6. PubMed ID: 7557562
[TBL] [Abstract][Full Text] [Related]
15. Extracapsular axillary node extension in patients receiving adjuvant systemic therapy: an indication for radiotherapy?
Fisher BJ; Perera FE; Cooke AL; Opeitum A; Dar AR; Venkatesan VM; Stitt L; Radwan JS
Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):551-9. PubMed ID: 9231679
[TBL] [Abstract][Full Text] [Related]
16. [Concurrent chemoradiation with paclitaxel and platinum for locally advanced esophageal cancer].
Zhang P; Xie CY; Wu SX
Zhonghua Zhong Liu Za Zhi; 2007 Oct; 29(10):773-7. PubMed ID: 18396692
[TBL] [Abstract][Full Text] [Related]
17. Conformal re-irradiation of recurrent and new primary head-and-neck cancer.
Dawson LA; Myers LL; Bradford CR; Chepeha DB; Hogikyan ND; Teknos TN; Terrell JE; Wolf GT; Eisbruch A
Int J Radiat Oncol Biol Phys; 2001 Jun; 50(2):377-85. PubMed ID: 11380224
[TBL] [Abstract][Full Text] [Related]
18. Is extended volume external beam radiation therapy covering the anastomotic site beneficial in post-esophagectomy high risk patients?
Yu E; Dar R; Rodrigues GB; Stitt L; Videtic GM; Truong P; Tomiak A; Ash R; Brecevic E; Inculet R; Malthaner R; Vincent M; Craig I; Kocha W; Lefcoe M
Radiother Oncol; 2004 Nov; 73(2):141-8. PubMed ID: 15542160
[TBL] [Abstract][Full Text] [Related]
19. [Patterns of recurrence in patients with stage Ⅲ thoracic esophageal squamous cell carcinoma after radical resection].
Wang YX; Yang Q; He M; Qiu R; Li J; Zhu SC; Qiao XY; Qi Z
Zhonghua Zhong Liu Za Zhi; 2017 Jan; 39(1):48-55. PubMed ID: 28104034
[No Abstract] [Full Text] [Related]
20. Involved-field irradiation concurrently combined with nedaplatin/5-fluorouracil for inoperable esophageal cancer on basis of (18)FDG-PET scans: a phase II study.
Yamashita H; Omori M; Takenaka R; Okuma K; Kobayashi R; Ohtomo K; Nakagawa K
Radiother Oncol; 2014 Nov; 113(2):182-7. PubMed ID: 25466372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
